Nomura Small Cap Core R holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Nomura Small Cap Core Fund Class R DCCRX
- NAV / 1-Day Return 32.89 / −0.51 %
- Total Assets 5.5B
-
Adj. Expense Ratio
1.290%
- Expense Ratio 1.290%
- Distribution Fee Level Below Average
- Share Class Type Retirement, Medium
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 26%
USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DCCRX
Will DCCRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Semtech Corp | 4.04 | 223M | Technology |
MYR Group Inc | 2.02 | 111M | Industrials |
Modine Manufacturing Co | 1.98 | 109M | Consumer Cyclical |
Axsome Therapeutics Inc | 1.83 | 101M | Healthcare |
Travere Therapeutics Inc Ordinary Shares | 1.78 | 98M | Healthcare |
Credo Technology Group Holding Ltd | 1.76 | 97M | Technology |
Silicon Laboratories Inc | 1.65 | 91M | Technology |
Ligand Pharmaceuticals Inc | 1.62 | 89M | Healthcare |
Arcosa Inc | 1.56 | 86M | Industrials |
ESCO Technologies Inc | 1.54 | 85M | Technology |